Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroFlow’s platform uses AI models trained on clinical data such as PHQ‑9 scores to identify patients at risk of depression with high sensitivity (~88%+). It supports providers by integrating behavioral insights into care workflows to improve outcomes in medically complex populations. The platform also enables remote monitoring without requiring patient app downloads via its BHIQ analytics product. Recent research published by NeuroFlow demonstrates improved detection of suicidal ideation using their technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuroFlow.